Management of severe and difficult-to-treat asthma

G. Brusselle (Ghent, Belgium)

Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping
Session: Severe asthma: moving from phenotyping to endotyping
Session type: Symposium
Number: 1768
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Brusselle (Ghent, Belgium). Management of severe and difficult-to-treat asthma. Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011


Management of severe asthma in children
Source: Virtual Congress 2020 – Reducing the burden of asthma
Year: 2020


Management of severe asthma in children
Source: Annual Congress 2010 - ERS/[italic]Lancet[/italic] Asthma
Year: 2010


Management of severe asthma in children
Source: International Congress 2018 – ME11 Management of severe asthma in children FULLY BOOKED
Year: 2018


ME11 Management of severe asthma in children
Source: Paris 2018 - Educational material
Year: 2018

Severe therapy-resistant asthma
Source: International Congress 2016 – PG8 Paediatric asthma
Year: 2016



Evaluation of the difficult-to-treat severe asthma patient in the clinic
Source: Eur Respir Mon 2011; 51: 16-27
Year: 2011


Characterisation of patients with difficult-to-treat and treatment-resistant severe asthma
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012

Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016



Evaluation and management of difficult-to-control asthma
Source: Annual Congress 2004 - PG12 - Asthma: from bench to bedside
Year: 2004


Risk factors of frequent exacerbations in difficult-to-treat asthma
Source: Eur Respir J 2006; 27: 1324-1325
Year: 2006


Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008



Sesonal variations of severe asthma exacerbations in the US
Source: International Congress 2014 – Risk factors for respiratory disease
Year: 2014

Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017

The use of omalizumab in the management of severe chronic paediatric asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Severe asthma
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019

Severe asthma
Source: ISSN=ISSN 1810-6838, ISBN=, page=128
Year: 2006

Severe asthma
Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD
Year: 2014